Lloyd’s Lab has announced the 11 companies it has selected for its sixth accelerator programme.
Companies were selected based on their ability to tackle some of the key themes Lloyds Lab is working to combat. These include climate change and decarbonisation, and geopolitics.
This latest cohort attracted 117 applications, but only 11 companies were selected.
The accelerator programme lasts ten weeks and will commence on April 26.
Tesselo is one of the companies to make the cohort. The geospatial intelligence firm helps to monitor natural resources and reduce climate risks.
CarbonChain, another one of the cohort, also aims to help reduce carbon risks through its platform that automates the accounting of carbon emissions.
The final company of the group aimed at climate risks is Jupiter Intelligence. The company offers climate risk analytics, which is helping insurance, asset management, banking, chemicals, mining, oil and gas, pharmaceuticals and power, to better understand climate change around the world.
Moonshot is also in the cohort, The analytics company offers builds technology to map extremism, disinformation and organised crime. Another one of the companies is Scrub AI. The InsurTech specialises in automating the repetitive task of data cleansing or ‘scrubbing’.
The next company is Verisk Maplecroft, which uses risk analytics and expert analysis to help companies manage risks that can undermine commercial value, damage brand reputation and disrupt global operations, investments and supply chains.
Other companies in the cohort are distriBind, which uses AI to improve efficiency in delegated authority, SettleIndex, a litigation risk platform, Safekeep, an AI subrogation solution that increases the number of recoverable claims, and Supercede Technology, which helps cedents and brokers automate the creation of submission packs.
Lloyd’s Lab also said it has a “wildcard” in the cohort, which does not meet its key themes but is offering something it finds exciting. The “wildcard” is Gaia, which offers an insurance product to make IVF treatments more accessible, affordable and personal.
Copyright © 2021 FinTech Global
